Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round
Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round. The company is developing novel small molecule drugs that limit neuronal damage in patients that have suffered a stroke, traumatic brain injury (TBI) or concussion.
The seed financing round was led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others. Read more >>